NCT05087745View on ClinicalTrials.gov

A Clinical Study on TIL for the Treatment of Advanced Solid Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 10, 2021

Primary Completion Date

December 10, 2024

Study Completion Date

December 10, 2025

Conditions
Advanced Solid TumorTumor Infiltrating LymphocytesTreatment Side EffectsEffects of Immunotherapy
Interventions
BIOLOGICAL

Tumor Infiltrating Lymphocytes

Adoptive transfer of 1x10\^9-5x10\^10 autologous TILs to patients i.v. in 30-120 minutes.

Trial Locations (1)

310016

RECRUITING

Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine, Hangzhou

All Listed Sponsors
collaborator

Sir Run Run Shaw Hospital

OTHER

lead

Shanghai Juncell Therapeutics

INDUSTRY